The role of phosphodiesterase inhibitors in impotence
- 1 December 1997
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 6 (12) , 1803-1810
- https://doi.org/10.1517/13543784.6.12.1803
Abstract
Penile erection is mediated by nitric oxide (NO) and its second messenger cyclic guanosine monophosphate (cGMP). The activity of cGMP is modulated by the enzyme phosphodiesterase (PDE). The most important physiological isoform of the enzyme in the penis is PDE5. Sildenafil is a specific inhibitor of this enzyme which potentiates nitrergic cavernosal relaxation in vitro and in animals. Clinical studies suggest that it is effective in the treatment of male erectile dysfunction (MED), which would make it the first orally active therapy for this condition.Keywords
This publication has 12 references indexed in Scilit:
- Integrative erectile biology: the role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erectionInternational Journal Of Impotence Research, 1997
- Cyclic nucleotide phosphodiesterase in human cavernous smooth muscleWorld Journal of Urology, 1997
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995
- Diversity in Cyclic Nucleotide Phosphodiesterase Isoenzyme FamiliesArchives of Biochemistry and Biophysics, 1995
- Colocalization of vasoactive intestinal polypeptide and nitric oxide in penis-innervating neurons in the major pelvic ganglion of the ratNeuroscience Research, 1995
- Role of Nitric Oxide in the Physiology of Erection1Biology of Reproduction, 1995
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Effect of Yohimbine Hydrochloride on Erectile Impotence: A Double-Blind StudyJournal of Urology, 1989
- DOUBLE-BLIND TRIAL OF YOHIMBINE IN TREATMENT OF PSYCHOGENIC IMPOTENCEThe Lancet, 1987
- Is Yohimbine Effective in the Treatment of Organic Impotence? Results of a Controlled TrialJournal of Urology, 1987